secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001140361-24-026254
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STRATA Skin Sciences Q1 revenue $6.8M (-11% YoY); net loss widens to $3.4M
--------------------------------------------------------------------------

- Revenue $6.8M vs $7.6M YoY; global recurring revenue $4.7M (-10% YoY).
- Net loss $3.4M ($0.10 per share) vs $2.8M ($0.08) in Q1 2023.
- Gross margin fell to 46% from 58% YoY; operating expenses cut 14% to $6.0M.
- Domestic installed base: 907 XTRAC (down from 923 in Dec 2023); 104 TheraClear X (up from 92).
- Amended credit agreement with MidCap Financial; renewed 3-year exclusive distributor deals in China and Japan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036124026254/0001140361-24-026254-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036124026254/ef20029015_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-026254

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer